Bio-Rad Laboratories, Inc. BIOB
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.66B | 1.62B | 1.56B | 1.54B | 1.42B |
| Total Receivables | 433.30M | 450.70M | 439.50M | 472.50M | 474.20M |
| Inventory | 783.90M | 780.60M | 770.50M | 740.70M | 783.20M |
| Prepaid Expenses | 160.70M | 147.80M | 150.00M | 136.50M | 152.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.40M | 22.90M | 17.40M | 15.80M | 14.00M |
| Total Current Assets | 3.08B | 3.02B | 2.94B | 2.91B | 2.84B |
|
|
|||||
| Total Current Assets | 3.08B | 3.02B | 2.94B | 2.91B | 2.84B |
| Net Property, Plant & Equipment | 652.80M | 671.90M | 689.40M | 709.90M | 720.50M |
| Long-term Investments | 573.00M | 574.30M | 577.10M | 579.80M | 578.70M |
| Goodwill | 573.00M | 574.30M | 577.10M | 579.80M | 578.70M |
| Total Other Intangibles | 104.40M | 160.00M | 166.80M | 174.30M | 388.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 102.00M | 102.70M | 103.90M | 103.80M | 110.20M |
| Total Assets | 10.78B | 10.25B | 9.79B | 10.58B | 9.70B |
|
|
|||||
| Total Accounts Payable | 133.50M | 143.50M | 133.10M | 129.00M | 128.80M |
| Total Accrued Expenses | 210.30M | 150.50M | 148.40M | 172.30M | 182.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 432.70M | 434.30M | 436.70M | 37.40M | 38.10M |
| Total Finance Division Other Current Liabilities | 192.60M | 233.00M | 198.80M | 178.30M | 172.60M |
| Total Other Current Liabilities | 192.60M | 233.00M | 198.80M | 178.30M | 172.60M |
| Total Current Liabilities | 969.10M | 961.30M | 917.00M | 517.00M | 522.30M |
|
|
|||||
| Total Current Liabilities | 969.10M | 961.30M | 917.00M | 517.00M | 522.30M |
| Long-Term Debt | 794.80M | 794.60M | 794.30M | 1.19B | 1.19B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 135.90M | 141.50M | 147.20M | 154.40M | 164.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.28B | 1.18B | 1.08B | 1.26B | 1.08B |
| Total Liabilities | 3.18B | 3.08B | 2.94B | 3.12B | 2.96B |
|
|
|||||
| Common Stock & APIC | 470.10M | 502.90M | 490.50M | 476.00M | 461.90M |
| Retained Earnings | 8.48B | 8.02B | 7.65B | 8.18B | 7.46B |
| Treasury Stock & Other | -1.35B | -1.35B | -1.29B | -1.20B | -1.18B |
| Total Common Equity | 7.60B | 7.17B | 6.85B | 7.45B | 6.74B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.60B | 7.17B | 6.85B | 7.45B | 6.74B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.60B | 7.17B | 6.85B | 7.45B | 6.74B |
|
|
|||||